Recently, comprehension of immune mechanisms involved in anti-tumor responses has permitted the development of new oncologic drugs called immune checkpoint inhibitors. These drugs act by restoring anti-tumor responses. With their increasing use, we note a rise in the incidence rate of immune related adverse events, which can affect many organs. Renal toxicity, more precisely tubulointerstitial nephritis, is still not well understood but an emerging complication.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
checkpoint inhibitors
8
anti-tumor responses
8
[immune checkpoint
4
inhibitors renal
4
renal toxicity
4
toxicity update
4
update emerging
4
emerging pathology]
4
pathology] comprehension
4
comprehension immune
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!